StockData
Waldencast plc logo

Waldencast plc (MLKMF) stock

MLKMFOTCPerfumes, Cosmetics & Other Toilet PreparationsAlso trades as MLKWF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 13, 2026Score 2/30
$0.88−0.01 (-0.92%)

Close on Oct 19, 2026Market cap –P/E –Yield –

Waldencast plc saw revenue fall 0.7% to $272.07M over fiscal 2025. Free cash flow was -$16.25M.

Revenue
$272.07M
-0.7% vs. a year earlier
Operating income
-$217.54M
FY2025
Free cash flow
-$16.25M
FY2025
EPS, diluted
-$2.01
FY2025

Key statistics

Valuation at the latest close; fundamentals over fiscal 2025, balances at Dec 31, 2025

Valuation

Market cap
–
P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–
Free cash flow yield
–

Fundamentals

Revenue
$272.07M
Net income
-$229.75M
EPS, diluted
-$2.01
Free cash flow
-$16.25M

Trading

Previous close
$0.89
Open
$0.75
Day's range
$0.75 – $0.91
Volume
2,595
Average volume (20 days)
176,452

Market cap history

Month-end market cap since 2021, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodMLKMFS&P 500DifferenceMLKMF per yearS&P 500 per year
1 month-24.1%+0.6%−24.8 pts
3 months-49.1%+3.4%−52.5 pts
Year to date-53.2%+13.3%−66.5 pts
1 year-53.4%+16.6%−70.0 pts
3 years-89.8%+86.4%−176.2 pts-53.3%+23.1%
5 years-91.0%+81.9%−172.9 pts-38.2%+12.7%

Seven years at a glance

Fiscal years 2019 to 2025, USD

Revenue

$272.07M-0.7% YoY

Gross profit

$183.02M-4.6% YoY

Operating income

-$217.54M

Net income

-$229.75M

EPS, diluted

-$2.01

Free cash flow

-$16.25M
Reported period

Press releases

Releases Waldencast filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About Waldencast

Perfumes, Cosmetics & Other Toilet Preparations

Waldencast plc operates a global multi-brand platform focused on developing, acquiring, and scaling beauty and wellness brands. The company conducts business through two primary operating segments: Obagi Medical and Milk Makeup. The Obagi Medical segment develops and markets medical-grade skincare, aesthetic solutions, and hyaluronic acid injectable fillers, catering to physicians, dermatologists, plastic surgeons, medical spas, and consumers via e-commerce and retail channels. The Milk Makeup segment offers clean, vegan, and cruelty-free prestige color cosmetics and skincare items, which appeal strongly to younger consumers and are distributed primarily through specialty beauty retailers and online storefronts.

Company profile, executives and history

Waldencast stock: common questions

What is Waldencast's stock price?

MLKMF closed at $0.88 on Oct 19, 2026, down 0.92% on the day.

What is MLKMF's P/E ratio?

Waldencast lost money over fiscal 2025 (diluted EPS -$2.01), so it has no meaningful P/E ratio.

How much revenue does Waldencast make?

Waldencast reported revenue of $272.07M for fiscal 2025, down 0.7% from a year earlier.

Does Waldencast pay a dividend?

No. Waldencast has not paid a cash dividend over the last twelve months.

How has MLKMF stock performed over the past year?

Including dividends, MLKMF returned -53.4% over the past year, against +16.6% for the S&P 500.

Who are Waldencast's competitors?

Companies most similar to Waldencast by business, industry and size include ODD, ELF, SLSN, IPAR, AXIL.

See a number that looks wrong?